LP
CVS icon

Longaeva Partners’s CVS Health CVS Stock Holding History

Longaeva Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
+35,732
New +$3.19M 0.08% 207

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Longaeva Partners's CVS Position: Q2 2026 in Review

Longaeva Partners opened a new position in CVS Health (CVS) in Q2 2026: 35,732 shares worth $3.7M. The stake represents 0.08% of the portfolio and ranks #207 among its holdings.

2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Longaeva Partners held 35,732 shares of CVS Health worth $3.7M as of Q2 2026.
  • CVS Health was a new Longaeva Partners position in Q2 2026.
  • CVS Health made up 0.08% of Longaeva Partners's portfolio in Q2 2026, its #207 holding.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.